Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions

Stem Cell Research

Volumn 11, Issue 3, 2013, Pages 1103-1116

  Wang, Ying ^a,b   Chou, Bin Kuan ^b   Dowey, Sarah ^b   He, Chaoxia ^b   Gerecht, Sharon ^a,c   Cheng, Linzhao ^b  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOPROCESS; CELL DIFFERENTIATION; CELL SUSPENSION; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMULATION; STEM CELL EXPANSION; SUSPENSION CELL CULTURE;

ANTIGENS, SURFACE; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; OCTAMER TRANSCRIPTION FACTOR-3; PROTEOGLYCANS; STAGE-SPECIFIC EMBRYONIC ANTIGENS;

EID: 84882993448     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.07.011     Document Type: Article

References (46)

1. Abaci H.E., et al. Microbioreactors to manipulate oxygen tension and shear stress in the microenvironment of vascular stem and progenitor cells. Biotechnol. Appl. Biochem. 2012, 59(2):97-105.
2. Abbasalizadeh S., et al. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng. Part C Methods 2012, 18(11):831-851.
3. Adamo L., et al. Biomechanical forces promote embryonic haematopoiesis. Nature 2009, 459(7250):1131-U120.
4. Amit M., et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 2011, 6(5):572-579.
5. Beers J., et al. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat. Protoc. 2012, 7(11):2029-2040.
6. Bigdeli N., et al. Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J. Biotechnol. 2008, 133(1):146-153.
7. Bilgen B., Barabino G.A. Location of scaffolds in bioreactors modulates the hydrodynamic environment experienced by engineered tissues. Biotechnol. Bioeng. 2007, 98(1):282-294.
8. Chen G.K., et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8(5):424-U76.
9. Chen V.C., et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 2012, 8(3):388-402.
10. Chou B.K., et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011, 21(3):518-529.
11. Collignon M.L., et al. Axial impeller selection for anchorage dependent animal cell culture in stirred bioreactors: methodology based on the impeller comparison at just-suspended speed of rotation. Chem. Eng. Sci. 2010, 65(22):5929-5941.
12. Cormier J.T., et al. Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng. 2006, 12(11):3233-3245.
13. Desbordes S.C., Studer L. Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat. Protoc. 2013, 8(1):111-130.
14. Dowey S.N., et al. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat. Protoc. 2012, 7(11):2013-2021.
15. Fluri D.A., et al. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat. Methods 2012, 9(5):509-516.
16. Hoeben A., et al. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 2004, 56(4):549-580.
17. Kehoe D.E., et al. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 2010, 16(2):405-421.
18. Krawetz R., et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng. Part C Methods 2010, 16(4):573-582.
19. Li Y., et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 2005, 91(6):688-698.
20. Li X., et al. ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum. Reprod. 2009, 24(3):580-589.
21. Ludwig T.E., et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 2006, 24(2):185-187.
22. Mehta J., et al. Optimizing the CD34+ cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation. Leuk. Lymphoma 2009, 50(9):1434-1441.
23. Ng E.S., et al. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 2005, 106(5):1601-1603.
24. Ng E.S., et al. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 2008, 3(5):768-776.
25. Niebruegge S., et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng. 2009, 102(2):493-507.
26. O'Connor K.C., Terry Papoutsakis E. Agitation effects on microcarrier and suspension CHO cells. Biotechnol. Tech. 1992, 6(4):323-328.
27. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-U1.
28. Olmer R., et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 2010, 5(1):51-64.
29. Olmer R., et al. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng. Part C Methods 2012, 18(10):772-784.
30. Papoutsakis E.T. Fluid-mechanical damage of animal cells in bioreactors. Trends Biotechnol. 1991, 9(12):427-437.
31. Singh H., et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 2010, 4(3):165-179.
32. Steiner D., et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 2010, 28(4):361-364.
33. Stover A.E., Schwartz P.H. Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging. Methods Mol. Biol. 2011, 767:137-146.
34. Sucosky P., et al. Fluid mechanics of a spinner-flask bioreactor. Biotechnol. Bioeng. 2004, 85(1):34-46.
35. Vallier L., Alexander M., Pedersen R.A. Activin/nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 2005, 118(Pt 19):4495-4509.
36. Venkat R.V., Stock L.R., Chalmers J.J. Study of hydrodynamics in microcarrier culture spinner vessels: a particle tracking velocimetry approach. Biotechnol. Bioeng. 1996, 49(4):456-466.
37. Wang L., et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 2007, 110(12):4111-4119.
38. Watanabe K., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25(6):681-686.
39. Yamamoto K., et al. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am. J. Physiol. Heart Circ. Physiol. 2005, 288(4):H1915-H1924.
40. Ye Z., et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009, 114(27):5473-5480.
41. Yirme G., et al. Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev. 2008, 17(6):1227-1241.
42. Youn B.S., et al. Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Biotechnol. Prog. 2006, 22(3):801-810.
43. Yu J.Y., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
44. Yu X., et al. Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell 2008, 2(5):461-471.
45. Zhan X., et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 2004, 364(9429):163-171.
46. Zweigerdt R., et al. Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 2011, 6(5):689-700.